IQVIA Asia Pacific
Welcome to IQVIA Biotech in Japan and Asia Pacific (JAPAC), the extension of IQVIA Biotech global, aimed at providing a custom-built delivery solution for emerging biopharma and biotech customers.
The growth of cell and gene therapies signals disruption for the entire healthcare ecosystem, requiring new thinking around development, administration, value, and reimbursement. IQVIA can help you develop and commercialize your therapy, and get ready for what's next.
The cost of high burden diseases, such as cancers, neurological disease and rare diseases, are significant and growing. This Thought Leadership page aims to identify and assess healthcare innovative funding trends and models, and to understand the possibilities of innovative funding while stressing key factors that enable sustainability and success.
